• You are here:
  • News
  • FDA Announces Meeting of Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee

On February 12, 2019, the FDA Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee will meet to discuss and make recommendations regarding the safety and effectiveness of surgical mesh placed transvaginally in the anterior vaginal compartment to treat pelvic organ prolapse.  FDA is convening this meeting to seek expert opinion on the evaluation of the risks and benefits of these devices.  The Committee will be asked to provide scientific and clinical input on assessing the effectiveness, safety, and benefit/risk of mesh placed transvaginally in the anterior vaginal compartment, as well as identifying the appropriate patient population and physician training needed for these devices.

For more information, click here.

Share This: